We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia (CHoPA-I)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00767091
Recruitment Status : Completed
First Posted : October 6, 2008
Last Update Posted : April 24, 2012
Information provided by (Responsible Party):
University Hospital, Lille